Latest Breaking News On - Gopi shanker - Page 1 : comparemela.com

Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results

Focused on Executing Three Strategic Pillars – Hematology, Immunology/Oncology and Genetic Diseases – Potential for Long-Term Pipeline Growth and Sustained Impact on Patient Lives . | May 10, 2023

Hope for haploinsufficiency diseases | Popular Science

Genetic conditions like Dravet syndrome are hard to tackle with traditional gene therapy. But new approaches are in the works.

Beam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief Scientific Officer

Beam Therapeutics Inc. (BEAM) Appoints Gopi Shanker as Chief Scientific Officer

Tevard Biosciences Appoints Zoya Ignatova to Its Scientific Advisory Board

/PRNewswire/ Tevard Biosciences, the pioneer of tRNA-based therapies for severe genetic diseases, today announced the appointment of leading tRNA scientist.